Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: Report of four cases

Radiology

Volumn 221, Issue 3, 2001, Pages 795-801

  Junghans, U ^a   Seitz, R J ^a   Wittsack, H J ^a   Aulich, A ^a   Siebler, M ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Arteries, basilar; Arteries, stenosis or obstruction; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; TIROFIBAN;

ADULT; AGED; ARTICLE; BASILAR ARTERY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035181196     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2213010444     Document Type: Article

References (36)

1. Basilar artery occlusion: Clinical and radiological correlation
2. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease
3. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease
4. Local intraarterial fibrinolysis in acute vertebrobasilar occlusion: Technical developments and recent results
5. Thrombolytic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome
6. Relationship between clot location and outcome after basilar artery thrombolysis
7. Collateral circulation and outcome after basilar artery thrombolysis
8. Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: Potential use in guiding thrombolytic therapy
9. Transcranial Doppler ultrasonography: Year 2000 update
10. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MR1
11. Treatment of acute ischemic stroke
12. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction
13. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator
14. Illusion of reperfusion: Does anyone achieve optimal reperfusion during acute myocardial infarction?
15. Reperfusion after thrombolytic therapy of embolic stroke in the rat: Magnetic resonance and biochemical imaging
16. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation
17. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IlIa integrin receptor blockade with Integrilin in acute myocardial infarction: Results of a randomized, placebo-controlled, dose-ranging trial
18. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
19. Tirofiban: A review of its use in acute coronary syndromes
20. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
21. Sticky platelet syndrome
22. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors
23. Molecular mechanisms of platelet activation
24. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
25. Incomplete resolution of basilar artery occlusion after intra-arterial thrombolysis: Abciximab and heparin prevent early rethrombosis
26. Intra-arterial thrombolysis in acute basilar artery thromboembolism: The initial Mayo Clinic experience
27. Thrombolytic treatment for acute occlusion of the basilar artery
28. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke
29. Lysis of basilar artery occlusion with tissue plasminogen activator
30. Infusion of recombinant tissue plasminogen activator for treatment of basilar artery occlusion
31. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization
32. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor
33. Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty
34. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (aI-phaIIbbeta3) inhibitors
35. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
36. Combined thrombolytic and platelet glycoprotein IIb/IIIa inhibitor therapy for acute myocardial infarction: Will pharmacological therapy ever equal primary angioplasty?